FTO and glioblastoma: Mutations of the two m6A “erasers” FTO and ALKBH5, as demonstrated by Cui et al., can facilitate malignant transformation of glioblastomas by promoting glioblastoma stem cell growth, self-renewal and tumor progression [17].